Cargando…

BMP and TGFβ use and release in bone regeneration

A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spi...

Descripción completa

Detalles Bibliográficos
Autores principales: BAL, Zeynep, KUSHIOKA, Junichi, KODAMA, Joe, KAITO, Takashi, YOSHIKAWA, Hideki, KORKUSUZ, Petek, KORKUSUZ, Feza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672355/
https://www.ncbi.nlm.nih.gov/pubmed/32336073
http://dx.doi.org/10.3906/sag-2003-127
_version_ 1783611116499238912
author BAL, Zeynep
KUSHIOKA, Junichi
KODAMA, Joe
KAITO, Takashi
YOSHIKAWA, Hideki
KORKUSUZ, Petek
KORKUSUZ, Feza
author_facet BAL, Zeynep
KUSHIOKA, Junichi
KODAMA, Joe
KAITO, Takashi
YOSHIKAWA, Hideki
KORKUSUZ, Petek
KORKUSUZ, Feza
author_sort BAL, Zeynep
collection PubMed
description A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spinal fusion cases also need special monitoring for healing. Bone tissue regeneration can be attained by autografts, allografts, xenografts and synthetic materials, however their limited availability and the increased surgical time as well as the donor site morbidity of autograft use, and lower probability of success, increased costs and disease transmission and immunological reaction probability of allografts oblige us to find better solutions and new grafts to overcome the cons. A proper biomaterial for regeneration should be osteoinductive, osteoconductive, biocompatible and mechanically suitable. Cytokine therapy, where growth factors are introduced either exogenously or triggered endogenously, is one of the commonly used method in bone tissue engineering. Transforming growth factor β (TGFβ) superfamily, which can be divided structurally into two groups as bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs) and TGFβ, activin, Nodal branch, Mullerian hormone, are known to be produced by osteoblasts and other bone cells and present already in bone matrix abundantly, to take roles in bone homeostasis. BMP family, as the biggest subfamily of TGFβ superfamily, is also reported to be the most effective growth factors in bone and development, which makes them one of the most popular cytokines used in bone regeneration. Complications depending on the excess use of growth factors, and pleiotropic functions of BMPs are however the main reasons of why they should be approached with care. In this review, the Smad dependent signaling pathways of TGFβ and BMP families and their relations and the applications in preclinical and clinical studies will be briefly summarized.
format Online
Article
Text
id pubmed-7672355
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-76723552021-09-28 BMP and TGFβ use and release in bone regeneration BAL, Zeynep KUSHIOKA, Junichi KODAMA, Joe KAITO, Takashi YOSHIKAWA, Hideki KORKUSUZ, Petek KORKUSUZ, Feza Turk J Med Sci Article A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spinal fusion cases also need special monitoring for healing. Bone tissue regeneration can be attained by autografts, allografts, xenografts and synthetic materials, however their limited availability and the increased surgical time as well as the donor site morbidity of autograft use, and lower probability of success, increased costs and disease transmission and immunological reaction probability of allografts oblige us to find better solutions and new grafts to overcome the cons. A proper biomaterial for regeneration should be osteoinductive, osteoconductive, biocompatible and mechanically suitable. Cytokine therapy, where growth factors are introduced either exogenously or triggered endogenously, is one of the commonly used method in bone tissue engineering. Transforming growth factor β (TGFβ) superfamily, which can be divided structurally into two groups as bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs) and TGFβ, activin, Nodal branch, Mullerian hormone, are known to be produced by osteoblasts and other bone cells and present already in bone matrix abundantly, to take roles in bone homeostasis. BMP family, as the biggest subfamily of TGFβ superfamily, is also reported to be the most effective growth factors in bone and development, which makes them one of the most popular cytokines used in bone regeneration. Complications depending on the excess use of growth factors, and pleiotropic functions of BMPs are however the main reasons of why they should be approached with care. In this review, the Smad dependent signaling pathways of TGFβ and BMP families and their relations and the applications in preclinical and clinical studies will be briefly summarized. The Scientific and Technological Research Council of Turkey 2020-11-03 /pmc/articles/PMC7672355/ /pubmed/32336073 http://dx.doi.org/10.3906/sag-2003-127 Text en Copyright © 2020 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
BAL, Zeynep
KUSHIOKA, Junichi
KODAMA, Joe
KAITO, Takashi
YOSHIKAWA, Hideki
KORKUSUZ, Petek
KORKUSUZ, Feza
BMP and TGFβ use and release in bone regeneration
title BMP and TGFβ use and release in bone regeneration
title_full BMP and TGFβ use and release in bone regeneration
title_fullStr BMP and TGFβ use and release in bone regeneration
title_full_unstemmed BMP and TGFβ use and release in bone regeneration
title_short BMP and TGFβ use and release in bone regeneration
title_sort bmp and tgfβ use and release in bone regeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672355/
https://www.ncbi.nlm.nih.gov/pubmed/32336073
http://dx.doi.org/10.3906/sag-2003-127
work_keys_str_mv AT balzeynep bmpandtgfbuseandreleaseinboneregeneration
AT kushiokajunichi bmpandtgfbuseandreleaseinboneregeneration
AT kodamajoe bmpandtgfbuseandreleaseinboneregeneration
AT kaitotakashi bmpandtgfbuseandreleaseinboneregeneration
AT yoshikawahideki bmpandtgfbuseandreleaseinboneregeneration
AT korkusuzpetek bmpandtgfbuseandreleaseinboneregeneration
AT korkusuzfeza bmpandtgfbuseandreleaseinboneregeneration